ð»ââïžãããããããã«ãŒããªãŒãç®ã«è¯ããšèšãããŠé·ãããæè¿ã§ã¯ã«ãã€ã³ã泚ç®ãéããŠãããããã®ããã
ðŠãããã ããããŸãããã§ããããã£ãŠæ¬åœã«ã©ã£ã¡ãå¹ãã®ãç§åŠçã«èšŒæãããŠãã®ããªïŒäž¡æ¹å¹ããªãïŸïŸïœžãåãå
¥ããããã©ïŒã
ð»ââïžããããªãæåãå¹èœãç§åŠçãªç ç©¶ãå«ããŠè©³ããèŠãŠã¿ãããã®ãã
ðŠãå€§è³æã ãïŒïŸïœš~ããªãã ãã¯ã¯ã¯ã¯ããŠããïŒã
ð»ââïžãã«ãŒããªãŒãšðŠã«ãã€ã³ïŒç§åŠãè£ä»ããç®ã®å¥åº·æŠç¥
ãã«ãŒããªãŒãšã«ãã€ã³ã¯ã©ã¡ããç®ã«è¯ããšèšãããŠããããããããã«ç¹åããå¹èœãããããããç§åŠçãªç ç©¶ããããããããç®ã®å¥åº·ç¶æã«æçã§ããããšãæ¯æãããŠããããã仿¥ã¯ãã®æåãå¹èœããããŠç§åŠçæ ¹æ ã«ã€ããŠè©³ãã解説ãããã
ð»ââïžãã«ãŒããªãŒïŒã¢ã³ãã·ã¢ãã³ãšãã®ç§åŠç广
æåãšå¹èœ
- ã¢ã³ãã·ã¢ãã³ïŒãã«ãŒããªãŒã®äž»æåã§ãç¶²èã®è¡æµãæ¹åããèŠèŠæ©èœããµããŒãããã
- æé žåäœçšïŒçްèãé žåã¹ãã¬ã¹ããå®ããç®ã®èåãç²åŽãé²ãã
- å€éèŠåã®æ¹åïŒäžéšã®ç ç©¶ã§ã¯ãã¢ã³ãã·ã¢ãã³ãæé å¿ïŒæéã§ç®ãæ £ããèœåïŒãå©ããããšã瀺åãããŠããã
ç§åŠçç ç©¶
- èŠèŠæ©èœæ¹åã®ç ç©¶
è«æã«ãããšããã«ãŒããªãŒç±æ¥ã®ã¢ã³ãã·ã¢ãã³ãçŒç²Ÿç²åŽã軜æžããç®ã®è¡æµãæ¹åããããšã確èªãããŠããã
äŸïŒ2012幎ã®ããç ç©¶ã§ã¯ããã«ãŒããªãŒãšãã¹ãæåãã被éšè ãé·æéã®ããžã¿ã«äœæ¥åŸãç®ã®ç²åŽã軜æžããããšããçµæãåºãŠããã - æé
žåã®äœçš
æé žåæåãšããŠã®ã¢ã³ãã·ã¢ãã³ã¯ãããªãŒã©ãžã«ã«ãäžåããç®ã®çµç¹ãä¿è·ããåããããšãããŠããã
ðŠã«ãã€ã³ïŒç®ã®ãã£ã«ã¿ãŒãšé»æéšä¿è·ã®ãšãã¹ããŒã
æåãšå¹èœ
- 黿è²çŽ ïŒã«ãã€ã³ã¯é»æéšïŒç¶²èã®äžå¿ïŒã«èç©ãããã«ãŒã©ã€ãã玫å€ç·ããç®ãä¿è·ãã倩ç¶ãã£ã«ã¿ãŒã
- æççäœçšïŒççãæãã广ãæåŸ ãããŠãããç®ã®çŸæ£ãªã¹ã¯ãäœæžããã
- å éœ¢é»æå€æ§çïŒAMDïŒã®äºé²ïŒã«ãã€ã³ãäžè¶³ãããšAMDã®ãªã¹ã¯ãé«ãŸãã
ç§åŠçç ç©¶
- ã«ãã€ã³ã®å
ä¿è·äœçš
2016幎ã®ããç ç©¶ã§ã¯ãã«ãã€ã³æåãç®ã®é»æè²çŽ å¯åºŠãé«ãããã«ãŒã©ã€ãã«ãããã¡ãŒãžã軜æžããããšã確èªãããŠããã - AMDäºé²ã®ãšããã³ã¹
å€§èŠæš¡ç ç©¶ãAREDS2ïŒAge-Related Eye Disease Study 2ïŒãã«ãããšãã«ãã€ã³ã®è£çµŠãå éœ¢é»æå€æ§çã®é²è¡ãæãã广ããããšå ±åãããŠããã
ð»ââïžðŠãã«ãŒããªãŒãšã«ãã€ã³ãäž¡æ¹æãå®è·µæ³
ç§åŠçã«èŠãŠãããã«ãŒããªãŒãšã«ãã€ã³ã®å¹æã¯è£å®çãããäžæ¹ãéžã¶ã®ã§ã¯ãªããäž¡æ¹ãåãå ¥ããããšã§ç®ã«å¯Ÿããå€è§çãªãµããŒããå¯èœã«ãªããããã
æ¥åžžç掻ã§ã®åãå ¥ãæ¹ïŒ
- æé£ïŒãã«ãŒããªãŒå ¥ããšãŒã°ã«ããæãã
- æŒé£ã»å€é£ïŒã»ãããèãã±ãŒã«ã®ãµã©ããã¹ãŒããã¡ãã¥ãŒã«å ããã
- ãã¶ãŒãïŒãã«ãŒããªãŒã®ã¿ã«ããæ¥œããã
- ãµããªã¡ã³ãïŒäž¡æ¹ããã©ã³ã¹ããè£ãããã®ãµããªãå©çšããã
ð»ââïžãŸãšãïŒç§åŠãšæ¥åžžã®èå
ãã«ãŒããªãŒã¯èŠèŠæ©èœã®ç¶æãšæé žåäœçšã«åªããã«ãã€ã³ã¯ç®ã®ãã£ã«ã¿ãŒåœ¹ãšããŠå 霢ã«ããç®ã®çŸæ£ãé²ãåããããç§åŠçç ç©¶ããããã®å¹èœãæ¯æããŠãããæ¥åžžçæŽ»ã«åãå ¥ãã䟡å€ã倧ãã«ãããããã
ðŠãããŸãããïŸïŸïœžããããããã«ãŒããªãŒãšã«ãã€ã³ãäž¡æ¹åãããšã«ãããïŒãã¶ãŒãããµã©ãããç®ã«è¯ãã£ãŠæããšããçŸå³ããæãããïŒã
ð»ââïžãããããããå¥åº·çãªæ®ããã®ç§èš£ããã®ãå
±ã«ç®ã倧åã«ããŠããããããã
ãæ¿ç±ïŒãâ»æ¯é±æŽæ°å®çžŸæ²èŒâ» 140äžåã·ã°ãã«ãâãã£ã2äžåæãããïŒïŒ
ð¯æåç·ã®çè« Ã å®è·µåã§ç£šãäžããââåžžåã®âã·ã°ãã«é ä¿¡ã¹ã¿ã³ãâããä»ããã«ã
ICTã»ããŠçè«ã»ãã¬ãŒã·ã¢SnRã»SmartTradeâŠ
äžçãåžå·»ããããããè¿ä»£æè³çè«ãèåãã
宿Šãã¬ãŒããŒãã¡ãâå
±åéçºâãã粟éã·ã°ãã«çŸ€ââ
ãã®åããSODAã·ãªãŒãºïŒ
ðSODA(FREE)ðïŒðãŸãã¯ç¡æã§ïŒé«ç²ŸåºŠã詊ããã£ã³ãã«ðµæ¥æ¬èªç
ð¥SODA(MB GOLD)ïŒéååŒã®ãããæŸã€ãäžæå¿
殺ã®ç Žå£åð¥
ð¥SODA(ICT THE BEST)ïŒããŠçè«ÃICTã®é»éæ¯ãé±é500pipsã¯åœããåã
ð¥SODA(CRT2nd)ïŒICTã«æ°ããªææ³ãå ããæ°é²æ°éã®ãã¬ãŒããŒãéãåç§ã®ã·ã°ãã«ã
ð¯SODA(DG)ïŒçææã®ãããªç確ãšã³ããªãŒð«ç²ŸåºŠã®é¬Œã
ðSODA(UK)ïŒãã€ããŒé貚ãç¶²çŸ
ïŒçã®ãªãŒã«ã©ãŠã³ããŒð
ð§ SODA(PK)ïŒSmartTradeã§âèãããã¬ãŒãâããµããŒãðâš
ð¬ãŠãœåœããã·ãæ·¡ã
ãšâåã¡âãç©ã¿äžããã
åçŸæ§ã®é«ãææ³ãšãªã¢ã«ãªçµæã«è£æã¡ããããä¿¡é Œã®ã·ã°ãã«é
ä¿¡ãââ
ð©ãŸãã¯ç¡æã§ãã®âæ¬ç©âããäœæããŠããã ããããšæããŸãã
ð¡ð€äºå©ãµãŒãã¹å ¥äŒã®ãæ¡å ð€ð¡
- å ¥äŒäŸ¡æ Œã¯ããããããäžåŸ Â¥2äžåïŒæãåãïŒ ã§ãã
- äžåºŠã®ãæ¯æãã§äžç涯䜿ããŸãïŒ
- ð³ãæ¯æãæ¹æ³ïŒPayPayãããŒééãPayPayæ¯èŸŒã«å¯Ÿå¿ããŠããŸãðŠ
ð§ããããã質åQïŒAâš
- â³ã·ã°ãã«ã®é
ä¿¡æéã¯ãã€ãŸã§ã§ããïŒ
â å ¥äŒããç¡å¶éã§ãã - ð»VPSã¯å¿
èŠã§ããïŒ
â EAãåããå Žåã¯VPSãå¿ èŠã§ããæé¡10ãã«ã§å©çšã§ããå®å®ããVPSããæ¡å ããŠããŸãã - â ïžæ³çãªãªã¹ã¯ã¯ãããŸããïŒ
â FXååŒã«ã¯ãªã¹ã¯ã䌎ããŸããåœã°ã«ãŒãã®ã·ã°ãã«ã¯åèæ å ±ãšããŠæäŸãããŠããŸãã®ã§ãèªå·±è²¬ä»»ã§ã®ååŒããé¡ãããŸãã
ãæ°è»œã«çžè«ãã ãã
ããŸãã¯ã©ããªã®ããèŠããŠã¿ãããã1æã ãå šæ©èœã䜿ã£ãŠã¿ããããªã©ãã詊ããªã©ããããããèŠæã«ãå¿ãããŸãããŸãã¯ãæ°è»œã«ã¡ãã»ãŒãžãéã£ãŠã¿ãŠãã ããã
2025幎4æ4é±ïŒ4æ19æ¥ïœ4æ25æ¥ïŒã®çµæ
ð»ââïž é貚ïŒXAUUSD
è²·ãïŒïŒ950 pipsïŒR:RïŒ1ïŒ12ïŒâš
è²·ãïŒïŒ480 pipsïŒR:RïŒ1ïŒ5.2ïŒâš
è²·ãïŒïŒ930 pipsïŒR:RïŒ1ïŒ6.5ïŒâš
è²·ãïŒïŒ620 pipsïŒR:RïŒ1ïŒ5ïŒâš
è²·ãïŒïŒ1050 pipsïŒR:RïŒ1ïŒ6.5ïŒâš
è²·ãïŒÂ±0 pipsïŒBreakevenïŒð
è²·ãïŒïŒ100 pipsïŒR:RïŒ1ïŒ1ïŒð§
ð»ââïž é貚ïŒUSDCAD
è²·ãïŒïŒ160 pipsïŒR:RïŒ1ïŒ6ïŒâš
è²·ãïŒïŒ100 pipsïŒR:RïŒ1ïŒ4ïŒâš
ð»ââïž é貚ïŒUSDCHF
è²·ãïŒïŒ190 pipsïŒR:RïŒ1ïŒ3.3ïŒâš
ð»ââïž é貚ïŒEURJPY
è²·ãïŒïŒ200 pipsïŒR:RïŒ1ïŒ6ïŒâš
ð»ââïž é貚ïŒGBPJPY
è²·ãïŒïŒ45 pipsïŒR:RïŒ1ïŒ1ïŒð§
ð»ââïž é貚ïŒAUDUSD
è²·ãïŒïŒ30 pipsïŒR:RïŒ1ïŒ1ïŒð§
ð ããŒã¿ã«ãïŒ4,505 pips
ð æ¥æ¬åæç®ãïŒ968,000åïŒ1ãããæè³ãéã®å Žåã¯å©çã1/10æç®ïŒð
ãã¯ãªããPRããã£ãã·ã¥ããã¯å¶åºŠè±å¯ã®Bitrueãžãããã
Bitrueã®ç¹å¥ãã£ã³ããŒã³ããã²ãå©çšãã ããïŒ
ååå
¥éã§20%ãã£ãã·ã¥ããã¯ïŒððð
â° ã€ãã³ãæé: 2025幎4æ18æ¥ ïœ 2025幎4æ20æ¥ (UTC+8)
ð ãã£ã³ããŒã³1ïŒãªã³ã¯ãã¯ãªãã¯ããŠç»é²ãããšã10USDTã®ããŒãã¹ããã¬ãŒã³ãïŒå ç30åæ§éå®ïŒðð
ð ãã£ã³ããŒã³2ïŒæ°èŠãŠãŒã¶ãŒå
¥éããŒãã¹ïŒæå€§20%ã®å
¥éç¹å
žïŒïŒæå€§100USDTãŸã§ïŒ
1. çŽå
¥é100USDT â 20USDTã®äœéšè³éãã¬ãŒã³ã
2. çŽå
¥é300USDT â 60USDTã®äœéšè³éãã¬ãŒã³ã
3. çŽå
¥é500USDT â 100USDTã®äœéšè³éãã¬ãŒã³ã
â»ç·å ±é
¬ããŒã«ïŒ3000USDTã®äœéšè³éãå
çé ã§é
åžïŒïŒç·é¡3000USDTã«éãæ¬¡ç¬¬çµäºïŒïŒ
â»äœéšè³éã¯èªç±ã«å
¥åºéå¯èœïŒ
ð ãã£ã³ããŒã³3ïŒæ°èŠã»æ¢åãŠãŒã¶ãŒåãå
ç©ååŒç¹å
žïŒ
å
ç©ååŒé¡ã$200,000以äžã®å Žåã50USDTã®äœéšè³éããã¬ãŒã³ãïŒ